Green Thumb Industries (GTBIF) EBT Growth (3y) (2022 - 2026)
Green Thumb Industries (GTBIF) EBT Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | -26.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.06% |
| Mar 31, 2026 | 13.62% |
| Dec 31, 2025 | 61.24% |
| Sep 30, 2025 | 19.14% |
| Jun 30, 2025 | -29.28% |
| Mar 31, 2025 | -13.24% |
| Dec 31, 2024 | -4.37% |
| Sep 30, 2024 | -12.32% |
| Jun 30, 2024 | -0.30% |
| Mar 31, 2024 | 14.49% |
| Dec 31, 2023 | -17.76% |
| Sep 30, 2023 | 4.97% |
| Jun 30, 2023 | 121.82% |
| Mar 31, 2023 | 66.14% |
| Dec 31, 2022 | -79.13% |
| Sep 30, 2022 | 81.96% |
| Jun 30, 2022 | 71.32% |
| Mar 31, 2022 | 109.40% |